VCEL
VCEL clinical trials: Vericel Corp
Every trial on ClinicalTrials.gov where Vericel Corp is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 15
- Trials linked
- 14
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
VCEL on the catalyst calendar · VCEL registry changes
- Primary completion Jul 2030Sponsor estimatePhase 3NCT06915233A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the AnkleVericel Corporation · Chondral DefectRecruitingVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2030Sponsor estimatePhase 3NCT03588975A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the KneeVericel Corporation · Chondral DefectRecruitingVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 1, 2016ActualPhase 2NCT01670981An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With...Vericel Corporation · Ischemic Dilated Cardiomyopathy (IDCM)CompletedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 25, 2014ActualPhase 3NCT01483898An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)Vericel Corporation · Critical Limb IschemiaCompletedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 11, 2012ActualPhase 2NCT01020968Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated...Vericel Corporation · Dilated CardiomyopathyCompletedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 5, 2012ActualPhase 2NCT00765518Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)Vericel Corporation · Dilated CardiomyopathyCompletedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2015ActualNo phase registeredNCT01251588Extension Study for Participants of MACI00206 Study of MACI® for the Treatment of Symptomatic Articular Cartilage Defects of the KneeVericel Corporation · Articular Cartilage DefectsCompletedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2006ActualPhase 1/Phase 2NCT00797550Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine FusionVericel Corporation · Single Level Posterolateral Spinal FusionTerminatedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2012ActualPhase 3NCT00719576Superiority of MACI® Versus Microfracture Treatment in Patients With Symptomatic Articular Cartilage Defects in the KneeVericel Corporation · Articular Cartilage DefectCompletedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 1/Phase 2NCT00424567Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.Vericel Corporation · Fracture, UnunitedTerminatedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2005ActualPhase 4NCT00158613Study of the Treatment of Articular Repair (STAR)Vericel Corporation · Articular CartilageCompletedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2009ActualNo phase registeredNCT00140634The Objectives of the Cartilage Repair Registry is to Report Long Term Efficacy and Safety of Cartilage Repair Procedures in Registry...Vericel Corporation · Articular CartilageCompletedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2011ActualPhase 2NCT00468000Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb IschemiaVericel Corporation · Peripheral Arterial DiseaseCompletedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2010ActualPhase 3NCT00505219Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral HeadVericel Corporation · OsteonecrosisCompletedVCELLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2011ActualPhase 1/Phase 2NCT00755911Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell TherapyUniversity of Michigan · Alveolar Bone LossCompletedVCELCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 15 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner